Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2016
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,090
+49.96%
|
-
|
|
Jun 03
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
49,905
-30.52%
|
$4,092,210
$82.6 P/Share
|
|
Jun 03
2016
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
58,900
+16.64%
|
$2,473,800
$42.01 P/Share
|
|
Jun 01
2016
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Open market or private sale
|
Direct |
12,100
-11.06%
|
$968,000
$80.54 P/Share
|
|
Jun 01
2016
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Exercise of conversion of derivative security
|
Direct |
10,416
+12.06%
|
$374,976
$36.08 P/Share
|
|
May 02
2016
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+3.81%
|
-
|
|
May 02
2016
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+11.04%
|
-
|
|
May 02
2016
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+26.67%
|
-
|
|
May 02
2016
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+11.3%
|
-
|
|
May 02
2016
|
Shirley A Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+6.18%
|
-
|
|
May 02
2016
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+16.21%
|
-
|
|
May 02
2016
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+5.48%
|
-
|
|
May 02
2016
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+40.09%
|
-
|
|
May 02
2016
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+4.16%
|
-
|
|
May 02
2016
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+8.38%
|
-
|
|
May 02
2016
|
Robert C Pozen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+3.97%
|
-
|
|
May 02
2016
|
Preetha Reddy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,206
+22.0%
|
-
|
|
Apr 27
2016
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.31%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-1.06%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-4.12%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Shirley A Jackson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.53%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.46%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-13.22%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.34%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.75%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Robert C Pozen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.32%
|
$13,114
$79.45 P/Share
|
|
Apr 27
2016
|
Preetha Reddy Director |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-2.23%
|
$10,112
$79.45 P/Share
|
|
Apr 27
2016
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
221
-1.44%
|
$17,459
$79.45 P/Share
|
|
Apr 01
2016
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
4,000
-3.69%
|
$300,000
$75.22 P/Share
|
|
Mar 18
2016
|
Shirley A Jackson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,493
+4.55%
|
$68,678
$46.91 P/Share
|
|
Mar 18
2016
|
Shirley A Jackson Director |
SELL
Open market or private sale
|
Direct |
1,238
-3.99%
|
$92,850
$75.6 P/Share
|
|
Mar 17
2016
|
Omar Ishrak Executive Chairman |
SELL
Open market or private sale
|
Direct |
23,799
-1.91%
|
$1,808,724
$76.51 P/Share
|
|
Mar 15
2016
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
229,735
-26.89%
|
$17,459,860
$76.85 P/Share
|
|
Mar 15
2016
|
Omar Ishrak Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
323,013
+27.44%
|
$10,982,442
$34.88 P/Share
|
|
Mar 04
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
5,000
-4.91%
|
$375,000
$75.0 P/Share
|
|
Feb 18
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Payment of exercise price or tax liability
|
Direct |
3,323
-3.26%
|
$245,902
$74.97 P/Share
|
|
Feb 05
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
5,000
-4.68%
|
$380,000
$76.14 P/Share
|
|
Jan 08
2016
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
5,000
-4.48%
|
$375,000
$75.0 P/Share
|
|
Dec 04
2015
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
13,715
-11.26%
|
$1,069,770
$78.06 P/Share
|
|
Dec 04
2015
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
15,401
+11.23%
|
$739,248
$48.7 P/Share
|
|
Dec 01
2015
|
Bryan C Hanson EVP, President, MITG |
SELL
Payment of exercise price or tax liability
|
Direct |
3,907
-3.39%
|
$296,932
$76.51 P/Share
|
|
Oct 28
2015
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,642
-9.99%
|
$557,866
$73.54 P/Share
|
|
Sep 15
2015
|
Omar Ishrak Executive Chairman |
SELL
Open market or private sale
|
Direct |
20,000
-3.66%
|
$1,380,000
$69.43 P/Share
|
|
Aug 24
2015
|
Denise M Oleary Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,440
+5.35%
|
$304,640
$57.0 P/Share
|
|
Aug 03
2015
|
Gary Lee Ellis EVP & Global Ops and IT |
BUY
Grant, award, or other acquisition
|
Direct |
18,697
+9.7%
|
-
|
|
Aug 03
2015
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
10,257
+21.8%
|
-
|
|
Aug 03
2015
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
15,599
+14.91%
|
-
|
|
Aug 03
2015
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
9,830
+23.31%
|
-
|
|
Aug 03
2015
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
55,556
+9.22%
|
-
|
|
Aug 03
2015
|
Bryan C Hanson EVP, President, MITG |
BUY
Grant, award, or other acquisition
|
Direct |
12,394
+9.72%
|
-
|